Camp4 Therapeutics’ activist ownership position fell to 9.99%, representing 6,379,125 shares held by 5AM Ventures and affiliated reporting persons. For investors, the 13D classification identifies the position as activist rather than passive, while the stated purpose of the ownership is Venture Capital investments.
Key Highlights
- 5AM Ventures VII, L.P. and 5AM Partners VII, LLC each report beneficial ownership of 4,034,085 shares.
- The reporting persons identify venture capital investments as their principal Business purpose.
- Open-market sales occurred on 08/19/2026, 08/20/2026, 08/21/2026 and 08/24/2026, followed by a block sale on 08/27/2026.
5AM Group Reports CAMP (NASDAQ: CAMP) Position
5AM Ventures VI, L.P. and 5AM Partners VI, LLC each report beneficial ownership of 2,033,270 shares. The corresponding figures for 5AM Ventures VII, L.P. and 5AM Partners VII, LLC are 4,034,085 shares each. 5AM Opportunities II, L.P. and 5AM Opportunities II (GP), LLC each report beneficial ownership of 302,770 shares. Andrew J. Schwab and Dr. Kush Parmar are managing members of the relevant general partners and share voting and dispositive power over the positions held by the three Investment entities. The reduction included open-market sales by 5AM Ventures VI, L.P. on 08/19/2026, 08/20/2026, 08/21/2026 and 08/24/2026. A block sale by the same entity took place on 08/27/2026. The reporting persons’ ownership includes common stock held by 5AM Ventures VI, L.P. 5AM Ventures VII, L.P. and 5AM Opportunities II, L.P. along with vested stock Options held by Schwab. The reported position stands at 6,379,125 shares.
Ownership Blocker Limits Exercise
Pre-Funded Warrants held by 5AM Ventures VII, L.P. contain a beneficial ownership blocker that prevents exercise when it would cause ownership by the fund, its affiliates and other attribution parties to exceed 9.99% of Camp4 Therapeutics’ common stock. Schwab and Parmar may be deemed beneficial owners of the securities held by the investment entities. The reporting persons identify their principal business as venture capital investments.
Peers Moving on This News
- Alector, Inc. (NASDAQ: ALEC) little changed
- MacroGenics, Inc. (NASDAQ: MGNX) little changed
- Akebia Therapeutics, Inc. (NASDAQ: AKBA) down 0.8%




Please wait processing your request...